Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.

Shore ND, Antonarakis ES, Hafron J, Moses KA, Pieczonka C, Lowentritt B, Sheikh N, George DJ, Dorff TB

Open source

DOI
10.1155/proc/9766669
Published
2025
Container
Prostate cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/proc/9766669,
  title = {Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.},
  author = {Shore ND and Antonarakis ES and Hafron J and Moses KA and Pieczonka C and Lowentritt B and Sheikh N and George DJ and Dorff TB},
  year = {2025},
  journal = {Prostate cancer},
  doi = {10.1155/proc/9766669},
  url = {https://doi.org/10.1155/proc/9766669}
}

RIS

TY  - JOUR
TI  - Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.
AU  - Shore ND
AU  - Antonarakis ES
AU  - Hafron J
AU  - Moses KA
AU  - Pieczonka C
AU  - Lowentritt B
AU  - Sheikh N
AU  - George DJ
AU  - Dorff TB
PY  - 2025
JO  - Prostate cancer
DO  - 10.1155/proc/9766669
UR  - https://doi.org/10.1155/proc/9766669
ER  - 

APA

ND, S., ES, A., J, H., KA, M., C, P., B, L., N, S., DJ, G., & TB, D. (2025). Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-T.. Prostate cancer. https://doi.org/10.1155/proc/9766669

Source records